13th January 2026
Herbal Medicines and Dietary Supplements
Herbal Medicines and Dietary Supplements have been combined into one…
Knowledge products overview
Essential knowledge products and tools to support confident decision making
Evidence-based independent guidance, our trusted knowledge products and tools support health professionals manage patient safety at the point of need.
Expert guidance on the use and administration of drugs and medicines, our essential knowledge is regularly updated and easily accessed online through MedicinesComplete.
Our experienced editorial team of clinical and scientific writers triage new information, assess evidence, and robustly review all new and updated content before publication.
- 600k+
- Pages of evidence-based drug information
- 29
- Essential knowledge products
- 7,500+
- Drugs covered
- 150+
- Countries access MedicinesComplete
Our knowledge products cover six key areas:
Point of Need
Quick access to clear and concise medicines information, checking tools, and practical guidance for confident decision making at the point of need.
Our point of need knowledge products include:
Specialist
Evidence-based knowledge in areas of high-risk practice, including caring for patients during pregnancy and guidance to support the needs of the critically ill.
Our specialist knowledge products include:
Drug Administration
Expert knowledge to manage patient safety when administering drugs via enteral and injectable routes.
Our drug administration knowledge products include:
Reference
Comprehensive, practical, and authoritative, our reference knowledge products provide an extensive library of reference material.
Complementary and Alternative Medicine
Evidence-based information covering commonly available vitamins, minerals and trace elements in food, traditional uses of herbal medicines, and herb-drug interactions.
Our complementary and alternative medicine knowledge products include:
Legal and Regulatory
Helping health professionals stay compliant with updates on the latest laws, regulations, and standards in the UK.
Our legal and regulatory knowledge products include:
Latest knowledge updates
Our knowledge products are regularly updated online through MedicinesComplete
13th January 2026
Herbal Medicines and Dietary Supplements
Herbal Medicines and Dietary Supplements have been combined into one product containing
over 300 evidence-based herbal medicines monographs and expertly written dietary
supplements monographs in one easy-to-access, comprehensive product.
Changes include:
- General Principles chapters have replaced the Introductions, with minor changes.
- Updated substance names.
- The inclusion of preparations and supplier information for dietary supplements.
- Changes to how Herbal Medicines and Dietary Supplements content is displayed on MedicinesComplete to improve your user experience.
This update also contains globally updated British Pharmacopoeia, European Pharmacopoeia, and USP-NF information.
For more information on Herbal Medicines and Dietary Supplements, see our FAQs here.
Click to close
13th January 2026
British National Formulary
This update contains 15 significant changes, 3 dose changes, 4…
13th January 2026
British National Formulary
This update contains 15 significant changes, 3 dose changes, 4 new
monographs, 1 deleted monograph, and 1 deleted preparation.
Significant Changes:
- Azithromycin: updated indication and dose for uncomplicated gonorrhoea
and new indication and dose for gonococcal conjunctivitis. - Cefixime: updated indications and dose for uncomplicated gonorrhoea
and disseminated gonococcal infection. - Cefotaxime: deleted indication and dose for disseminated gonococcal
infection. - Ceftriaxone: updated indication for uncomplicated gonorrhoea and
updated indications and dose for disseminated gonococcal infections. - Cefuroxime: new indication and dose for gonococcal conjunctivitis.
- Ciprofloxacin: updated indication and dose for disseminated gonococcal
infection. - Fluorouracil: new indication and dose for actinic keratosis.
- Genital system infections, antibacterial therapy: updated guidance for
management of gonorrhoea: uncomplicated. - Herpesvirus infections: updated guidance for post-exposure prophylaxis
against chickenpox or shingles. - Immunoglobulins: updated guidance for uses of normal immunoglobulin
and varicella-zoster immunoglobulin. - Life support algorithm (image): adult advanced life support algorithm
image updated. - Normal immunoglobulin: new dosing for post-exposure prophylaxis of
varicella-zoster infection. - Ofloxacin: new indications and dose for gonococcal urethritis and
gonococcal cervicitis, and deleted indications and dose for
uncomplicated gonorrhoea and disseminated gonococcal infection. - Prescribing in palliative care: updated guidance for opioid dose
conversions. - Varicella-zoster vaccines: updated guidance for pre-exposure prophylaxis
against varicella (chickenpox) and immunisation against herpes zoster
(shingles).
Dose Changes:
- Herpes-zoster vaccine (recombinant, adjuvanted) [update to age range for immunisation against herpes zoster (shingles) in patients with severe immunosuppression].
- Lidocaine hydrochloride [update to dose for ventricular fibrillation or pulseless ventricular tachycardia refractory to defibrillation [for cardiopulmonary resuscitation as an alternative to amiodarone]].
- Varicella-zoster vaccine [update to dose interval for immunisation against varicella infection (chickenpox) for adults and children aged 1 year and older].
New Monographs:
- Hetronifly® [serplulimab].
- Jaypirca® [pirtobrutinib].
- Skyclarys® [omaveloxolone].
- Tepezza® [teprotumumab].
Deleted Monographs: Varicella-zoster immunoglobulin
Deleted Preparations: Varicella-zoster immunoglobulin solution for injection (Bio Products Laboratory).
Click to close
13th January 2026
BNF for Children
This update contains 15 significant changes, 4 dose changes, 1…
13th January 2026
BNF for Children
This update contains 15 significant changes, 4 dose changes, 1 new monograph,
1 new preparation, and 1 deleted preparation.
Significant Changes:
- Aciclovir: new dosing for post-exposure prophylaxis of varicella zoster infection.
- Azithromycin: updated indication and dose for uncomplicated gonorrhoea and new indication and dose for gonococcal conjunctivitis.
- Budesonide with formoterol (Symbicort 100/6 Turbohaler®): updated dosing for asthma, maintenance and reliever therapy.
- Cefixime: updated indications and dose for uncomplicated gonorrhoea and disseminated gonococcal infection.
- Cefotaxime: deleted indication and dose for disseminated gonococcal infection.
- Ceftriaxone: updated indication for uncomplicated gonorrhoea and updated indications and dose for disseminated gonococcal infections.
- Cefuroxime: new indication and dose for gonococcal conjunctivitis.
- Ciprofloxacin: updated indication and dose for disseminated gonococcal infection.
- Genital system infections, antibacterial therapy: updated guidance for management of gonorrhoea: uncomplicated.
- Herpesvirus infections: updated guidance for post-exposure prophylaxis against chickenpox or shingles.
- Immunoglobulins: updated guidance for uses of normal immunoglobulin and varicella-zoster immunoglobulin.
- Life support algorithm (image): newborn life support algorithm, paediatric basic life support algorithm, paediatric out-of-hospital basic life support algorithm, and paediatric advanced life support algorithm images updated.
- Normal immunoglobulin: new dosing for post-exposure prophylaxis of varicella-zoster infection.
- Ofloxacin: deleted indication and dose for disseminated gonococcal infection.
- Varicella-zoster vaccines: updated guidance for pre-exposure prophylaxis against varicella (chickenpox).
Dose Changes:
- Aciclovir [update to neonate dose for varicella zoster (chickenpox), treatment].
- Amiodarone hydrochloride [update to dose for ventricular fibrillation or pulseless ventricular tachycardia refractory to defibrillation [for cardiopulmonary resuscitation]].
- Varicella-zoster immunoglobulin [update to indications and dose].
- Varicella-zoster vaccine [update to dose interval for immunisation against varicella infection (chickenpox) for children aged 1 year and older].
New Monographs:
- Skyclarys® [omaveloxolone].
New Preparations: Varitect CP® [varicella-zoster immunoglobulin]
Deleted Preparations: Varicella-zoster immunoglobulin solution for injection (Bio Products Laboratory).
Click to close
13th January 2026
Palliative Care Formulary
This update contains 1 new monograph and 3 revised monographs….
13th January 2026
Palliative Care Formulary
This update contains 1 new monograph and 3 revised monographs.
The following monograph is new: Dexmedetomidine.
The following monographs have been partially updated: Appendix 3:
Compatibility charts 10 and 11 fully updated, Clonidine, Mirtazapine.
Click to close
13th January 2026
Stockley’s Interactions Checker
For January, 683 new interactions have been added, and 95…
13th January 2026
Stockley’s Interactions Checker
For January, 683 new interactions have been added, and 95 existing
interactions have been updated.
Click to close
13th January 2026
Electronic Medicines Compendium (emc)
For January, 30 new medicines have been added, and numerous…
13th January 2026
Electronic Medicines Compendium (emc)
For January, 30 new medicines have been added, and numerous medicines have
been amended.
Click to close
Request access today
Access our essential knowledge products through MedicinesComplete today.
Contact us now for pricing and access information.
The health profession is not just who we serve, it’s where we belong
Opens in a new window